Home / Research Articles Hub / Cardiovascular, mortality, and kidney outcomes wit...
🧬 Medicine & Biology OpenAlex

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

📅 Published: August 20, 2021 👤 Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen et al. 📖 The Lancet Diabetes & Endocrinology 📊 1,487 citations
AI-Generated Summary

This research explores Cardiovascular, mortality, and kidney outcomes with GLP-1 re..., contributing new insights to the field of Medicine & Biology.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

Key Findings
  • 1 Research demonstrates significant advances in patient outcome data
  • 2 Study provides new evidence regarding clinical efficacy results
  • 3 Findings open new directions for biological mechanism insights
Why It Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:

Read Full Paper at OpenAlex
More Medicine & Biology Papers ← Back to Hub 📚 Learning Hub
Article Details
Source OpenAlex
Category 🧬 Medicine & Biology
Published Aug 20, 2021
Journal The Lancet Diabetes & Endocrinology
DOI 10.1016/s2213-8587(21)00203-5
Citations 1,487
Authors Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato